Profilo
Matthew E.
Colpoys is the founder of Tactiva Therapeutics LLC.
He is currently an Independent Director at NeoDynamics AB, Chief Operating Officer at Efferent Labs, Inc., and President at Galileo Consulting, Inc. Previously, he was the President & Chief Executive Officer at Woodbrook Group Holdings, Inc. from 2008 to 2009.
He received his undergraduate degree from Canisius College.
Posizioni attive di Matthew E. Colpoys
| Società | Posizione | Inizio |
|---|---|---|
| NEOS AB | Direttore/Membro del Consiglio | 01/01/2021 |
Efferent Labs, Inc.
Efferent Labs, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company which focuses on implantable biosensors for life sciences | Direttore operativo | - |
Galileo Consulting, Inc. | Presidente | - |
Precedenti posizioni note di Matthew E. Colpoys
| Società | Posizione | Fine |
|---|---|---|
| WOODBROOK GROUP HOLDINGS INC. | Presidente | 07/01/2009 |
Tactiva Therapeutics LLC
Tactiva Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops adoptive cell therapies for cancer treatment | Amministratore Delegato | - |
Formazione di Matthew E. Colpoys
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Canisius College
Canisius College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Woodbrook Group Holdings, Inc.
Woodbrook Group Holdings, Inc. Investment ManagersFinance Provides financial advisory services | Finance |
NeoDynamics AB
NeoDynamics AB Medical SpecialtiesHealth Technology Develops equipment for diagnosis of breast cancer | Health Technology |
Efferent Labs, Inc.
Efferent Labs, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company which focuses on implantable biosensors for life sciences | Health Technology |
Tactiva Therapeutics LLC
Tactiva Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops adoptive cell therapies for cancer treatment | Health Technology |
Galileo Consulting, Inc. |
















